Clinical Trial

ECG Findings in Methamphetamine Use

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 9, 2026 (before its estimated April 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective cohort study aims to examine and compare electrocardiogram (ECG) parameters in subjects diagnosed with Methamphetamine Use Disorder (MUD) and Methamphetamine-Induced Psychotic Disorder (MP) during inpatient psychiatric treatment. ECG findings at hospital admission and during remission prior to discharge will be evaluated and compared between groups. The study also aims to determine whether methamphetamine-induced psychosis is associated with greater ECG abnormalities and increased cardiac risk compared to methamphetamine use without psychosis.
Trial Details
NCT Number NCT07459244
Lead Sponsor Elazığ Mental Health and Diseases Hospital
Conditions Methamphetamine Use Disorder, Methamphetamine Induced Psychosis
Enrollment 240 participants
Start Date 2025-04-07
Primary Completion 2026-04-06 (estimated)
Study Completion 2026-05-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-09